AI-driven discovery, EHR-based real-world evidence, and synthetic patient modeling are rapidly reshaping drug repurposing, reducing development timelines, expanding therapeutic applications, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback